World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
82
Citations
20674
World Ranking
1526
National Ranking
763

Overview

Julie Y. Djeu is affiliated with the University of South Florida in the United States. Their research primarily focuses on the fields of Immunology and Microbiology, with notable subfields including Immunology and Oncology.

Their scientific contributions address several key topics within immune system research, including:

  • Immune Cell Function and Interaction
  • T-cell and B-cell Immunology
  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses

Djeu's recent publications illustrate an engagement with natural killer (NK) cell biology and tumor immunology. One paper titled "Engineered Three-Dimensional Tumor Models to Study Natural Killer Cell Suppression," published in 2020 in ACS Biomaterials Science & Engineering, explores experimental models to understand NK cell behavior in tumor environments.

Another 2020 publication, "MicroRNA-155 governs SHIP-1 expression and localization in NK cells and regulates subsequent infiltration into murine AT3 mammary carcinoma," appeared in PLoS ONE, focusing on regulatory mechanisms affecting NK cell infiltration in cancer contexts.

Frequent collaborators in their research include Madison N. Temples, Isaac M. Adjei, Phoebe M. Nimocks, Blanka Sharma, and Wendy Kandell, indicating a network of ongoing coauthorship within their projects.

Their publications are featured in venues such as ACS Biomaterials Science & Engineering and PLoS ONE, highlighting interdisciplinary engagement between biomaterials science and broader biomedical research.

Best Publications

  • Natural Killer Cells: Characteristics and Regulation of Activity

    Ronald B. Herberman;Ronald B. Herberman;Ronald B. Herberman;Julie Y. Djeu;Julie Y. Djeu;Julie Y. Djeu;H. David Kay;H. David Kay;H. David Kay;John R. Ortaldo;John R. Ortaldo;John R. Ortaldo

  • Lymphokine-activated killer cell phenomenon. II. Precursor phenotype is serologically distinct from peripheral T lymphocytes, memory cytotoxic thymus-derived lymphocytes, and natural killer cells

    Elizabeth Ann Grimm;Keith M. Ramsey;Amitabha Mazumder;Debra J. Wilson

  • A Novel Chemoimmunomodulating Property of Docetaxel: Suppression of Myeloid-Derived Suppressor Cells in Tumor Bearers

    Krithika N. Kodumudi;Karrune Woan;Danielle L. Gilvary;Eva Sahakian

  • Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.

    A H Rook;H Masur;H C Lane;W Frederick

  • Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells.

    Kun Jiang;Bin Zhong;Danielle L. Gilvary;Brian C. Corliss

  • Circulating activated suppressor T lymphocytes in aplastic anemia.

    Nicholas C. Zoumbos;Pedro Gascón;Julie Y. Djeu;Stephen R. Trost

  • Interferon is a mediator of hematopoietic suppression in aplastic anemia in vitro and possibly in vivo.

    Nicholas C. Zoumbos;Pedro Gascon;Julie Y. Djeu;Neal S. Young

  • Growth inhibition of Candida albicans by human polymorphonuclear neutrophils: activation by interferon-gamma and tumor necrosis factor.

    J Y Djeu;D K Blanchard;D Halkias;H Friedman

  • Augmentation of natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic target cells.

    Ronald B. Herberman;Myrtel E. Nunn;Howard T. Holden;Steven Staal

  • Requirement for Ras/Rac1-mediated p38 and c-Jun N-terminal kinase signaling in Stat3 transcriptional activity induced by the Src oncoprotein.

    James Turkson;Tammy Bowman;Jalila Adnane;Yi Zhang

  • Induction of myelodysplasia by myeloid-derived suppressor cells.

    Xianghong Chen;Erika A. Eksioglu;Junmin Zhou;Ling Zhang

  • Capacity of human large granular lymphocytes (LGL) to produce multiple lymphokines: interleukin 2, interferon, and colony stimulating factor.

    T Kasahara;J Y Djeu;S F Dougherty;J J Oppenheim

  • Functional activation of human neutrophils by recombinant monocyte-derived neutrophil chemotactic factor/IL-8.

    J Y Djeu;K Matsushima;J J Oppenheim;K Shiotsuki

  • Human large granular lymphocytes are potent producers of interleukin-1

    Giuseppe Scala;Paola Allavena;Julie Y. Djeu;Tadashi Kasahara

  • Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors.

    Pearlie K. Epling-Burnette;Fanqi Bai;Jeffrey S. Painter;Dana E. Rollison

  • Cooperative regulation of Mcl-1 by Janus kinase/stat and phosphatidylinositol 3-kinase contribute to granulocyte-macrophage colony-stimulating factor-delayed apoptosis in human neutrophils

    P. K. Epling-Burnette;Bin Zhong;Fanqi Bai;Kun Jiang

  • Mechanistic role of heat shock protein 70 in Bcr-Abl–mediated resistance to apoptosis in human acute leukemia cells

    Fei Guo;Celia Sigua;Purva Bali;Prince George

  • Positive self regulation of cytotoxicity in human natural killer cells by production of interferon upon exposure to influenza and herpes viruses.

    J Y Djeu;N Stocks;K Zoon;G J Stanton

  • A critical role for phosphatase haplodeficiency in the selective suppression of deletion 5q MDS by lenalidomide

    Sheng Wei;Xianghong Chen;Kathy Rocha;P. K. Epling-Burnette

  • TGF-β–inducible microRNA-183 silences tumor-associated natural killer cells

    Sarah S. Donatelli;Jun-Min Zhou;Danielle L. Gilvary;Erika A. Eksioglu

  • Regulation of the mitogen-activated protein kinase signaling pathway by SHP2.

    Jess M. Cunnick;Songshu Meng;Yuan Ren;Caroline Desponts

Frequent Co-Authors

Sheng Wei
Sheng Wei University of South Florida
Alan F. List
Alan F. List Precision BioSciences
Thomas P. Loughran
Thomas P. Loughran University of Virginia
Thomas W. Klein
Thomas W. Klein University of South Florida
Herman Friedman
Herman Friedman University of South Florida
Ronald B. Herberman
Ronald B. Herberman University of Pittsburgh
John R. Ortaldo
John R. Ortaldo National Institutes of Health
Harvey M. Friedman
Harvey M. Friedman University of Pennsylvania
George C. Tsokos
George C. Tsokos Harvard Medical School
Jody Manischewitz
Jody Manischewitz US Food and Drug Administration

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens up diverse career pathways, especially in healthcare and research sectors. Many professionals in immunology transition into nursing specializations, where a strong understanding of the immune system can enhance patient care. For instance, nurses looking to advance can explore how to transition from fnp to acnp, enabling them to work in acute care settings with a focus on complex immunological conditions.

For those starting fresh in healthcare, enrolling in online programs can be a practical choice. Prospective students without a nursing background might consider online rn programs for non nurses, which provide a streamlined path into nursing, incorporating foundational science useful for immunology careers.

Accelerated programs also cater to individuals seeking faster entry into the nursing profession. Top options for these are detailed in the guide on accelerated nurse practitioner program, designed to prepare students efficiently for advanced clinical roles that often involve immunological expertise.

Moreover, earning advanced degrees can significantly impact earning potential. Understanding dnp salary variations helps in making informed decisions about specialization. Detailed insights into dnp salary by specialty shed light on lucrative pathways within nursing, especially for those focusing on immunology and related fields.

Best Scientists Citing Julie Y. Djeu

Trending Scientists